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ABSTRACT OF THESIS

SYNTHESIS AND DEVELOPMENT OF ZWITTERIONIC PEI (zPEI) FOR
OPTIMIZED DELIVERY OF NUCLEIC ACIDS
Gene therapy holds promise for the treatment a wide range of diseases ranging from
cystic fibrosis to cardiovascular disease to cancer. The need for safe and efficient gene
delivery methods remains the primary barrier to human gene therapy. Non-viral vector
materials, including polymers, can be designed to be biocompatible and non-immunogenic,
but lack the efficiency to be clinically relevant. Gene therapy awaits the development of
new materials that are both safe and efficient. Here, we have synthesized a series of
modified zwitterionic polymers based on the common transfecting agent polyethylenimine
(PEI). Using a variety of biochemical and biophysical methods we have studied structurefunction relation in zPEI-DNA as a function of percent modification. Our results show
significant structural rearrangements in the DNA condensates with increasing zwitterionic
character. The percent zwitterionic modification determines not only DNA packaging but
the serum stability of the resulting polyplexes with more highly modified zPEI releasing
DNA more readily.
KEYWORDS: Chemical Transfection Agents, Gene Therapy, Zwitterionic
Modifications, Biophysical Characterization, DNA Condensation

Joseph Raleigh Duke III
November 6, 2017

SYNTHESIS AND DEVELOPMENT OF ZWITTERIONIC PEI (zPEI) FOR
OPTIMIZED DELIVERY OF NUCLEIC ACIDS

By
Joseph Raleigh Duke III

Dr. Jason DeRouchey
Director of Thesis
Dr. Mark Lovell
Director of Graduate Studies
November 21, 2017

ACKNOWLEDGEMENTS
I would like to thank my advisor Dr. Jason DeRouchey for his mentorship,
guidance, and understanding throughout my graduate studies. Additionally, I would like
to acknowledge my group members Daniel Kirchoff, Xiaolu Zhang, Min An, Cody Gay,
Kanthi Nuti, Ehigbai Oikeh, Iris Begum, Kyle Starkey, Emily Fryman, and Leslie Uche for
their support, assistance, and friendship. Dr. Sean Parkin was instrumental in setting up
the small angle x-ray scattering experiments, and I am thankful for his time and expertise.
I am very appreciative of the assistance and perspective I was given by members of the
labs of Dr. Richards, Dr. Glazer, Dr. Miller, and Dr. Kim. Furthermore, I am grateful to
the University of Kentucky Chemistry Department and all the wonderful people I met
during my time here. I would like to thank Logan Warriner and Dr. Daniel Pack (UK
Chemical and Materials Engineering) for their collaboration on the modified PEI project,
and Johann Hansing and Dr. Roland Netz (Free University of Berlin) for their work on the
mixed charged diffusion project.
Finally, I would like to thank my friends and family for their love and support over
the course of my graduate studies and for sticking with me through the experience.

iii

TABLE OF CONTENTS
Acknowledgements ............................................................................................................. iii
List of Tables ...................................................................................................................... vi
List of Figures .................................................................................................................... vii
Chapter One: Introduction
1.1 Introduction to Gene Delivery by Chemical Transfectors ............................................1
1.2. Structure of Polymer Based Transfection Agents ........................................................5
1.3. Mechanism of DNA Binding and Delivery .................................................................8
1.4. Attempts to Optimize Gene Delivery ........................................................................13
Chapter Two: Synthesis and Characterization of Zwitterionic PEI
2.1. Introduction ................................................................................................................16
2.2. Materials and Methods...............................................................................................16
2.2.1. Materials .....................................................................................................16
2.2.2. Synthesis and Characterization of zPEI .....................................................17
2.2.2.1. Synthesis and Purification of Succinylated PEI ..........................17
2.2.2.2. H-NMR and FTIR Analysis .........................................................18
2.2.2.3. pH Titration..................................................................................19
2.2.3. Characterization of DNA Polyplex Formation ...........................................19
2.2.3.1. Gel Retardation Assay .................................................................19
2.2.3.2. Polyplex stability in the presence of Dextran sulfate...................20
2.2.3.3. DLS Zeta Potential Characterization ...........................................21
2.3. Results and Discussion ..............................................................................................21
2.3.1. Characterization of Synthetic Product .......................................................21
2.3.1.1. Spectroscopic Analysis of zPEI ..................................................21
2.3.1.2. Effect of Percent Succinylation on Buffering Capacity of zPEI...25
2.3.2. Characterization of Complex Formation and Dissociation .........................27
2.3.2.1. Complex Formation and Dissociation of zPEI ...........................27
2.3.2.2. Comparison of binding and release properties of a charge neutral
modification .................................................................................35
2.3.2.3. zPEI leads to improved transfectibility and lowered cytotoxicity
in HeLa cells ...............................................................................38
2.4. Conclusions ................................................................................................................40
Chapter Three: Analysis of Internal Structure of zPEI/DNA Complexes by Small Angle
X-ray Scattering
3.1. Introduction ................................................................................................................42
3.2. Background on Small Angle X-ray Scattering ..........................................................44
3.2.1. Generation of X-rays ..................................................................................44
3.2.2. Small Angle X-ray Scattering (SAXS) Theory .........................................45
3.3. Materials and Methods...............................................................................................49
3.3.1. Materials .....................................................................................................49
iv

3.3.2. Sample Preparation .....................................................................................49
3.3.3. Instrumental Setup ......................................................................................50
3.4. Results and Discussion ..............................................................................................52
3.5. Conclusions and Future Work ...................................................................................58
Appendix: Diffusion in Polymer Gels with Competing Interaction Sites
A.1. Introduction ...............................................................................................................60
A.2. Materials and Methods ..............................................................................................62
A.2.1. Materials.....................................................................................................62
A.2.2. Preparation of Dextran Solutions ...............................................................62
A.2.3. FCS Setup ..................................................................................................63
A.2.4. FCS Data Analysis ....................................................................................64
A.3. Results and Discussion .............................................................................................65
A.4. Conclusions ...............................................................................................................74
References ..........................................................................................................................75
Vita.....................................................................................................................................82

v

LIST OF TABLES
Table 2.1. Extent of buffering of succinylated bPEI derivatives .......................................27
Table 2.2. DLS and Zeta Potential Measurement of zPEI Derivatives .............................34

vi

LIST OF FIGURES
Figure 1.1. Structures of common polymer transfection agents .........................................6
Figure 1.2. Cellular barriers for effective chemical transfection .......................................9
Figure 2.1. Reaction scheme for the synthesis of succinylated PEI (zPEI) using succinic
anhydride. .....................................................................................................22
Figure 2.2. Potential side reactions, including succinimide group formation (left) and
crosslinking between amines (right) ...............................................................23
Figure 2.3. FTIR Analysis of Succinylated bPEI Derivatives ..........................................24
Figure 2.4 Titration of zPEI Derivatives with HCl. ...........................................................26
Figure 2.5. a) simple schematic of agarose gel electrophoretic on plasmid DNA. b)
representative gel bands of the supercoiled (s), nicked open coiled (n), and
linear variants (l) of pUC19 plasmid next to a 1 kB DNA ladder ..................29
Figure 2.6. Gel retardation assay of zPEI complexation with pUC19 plasmid. ................31
Figure 2.7. Dextran Sulfate Release Assay of zPEI complexation with pUC19 plasmid .32
Figure 2.8 Reaction scheme for the synthesis of acetylated PEI using acetic anhydride .35
Figure 2.9. Gel retardation Assay of acPEI complexation with pUC19 plasmid ..............36
Figure 2.10. Dextran Sulfate Release Assay of acPEI complexation with pUC19 plasmid
at a PEI/DNA weight ratio of 6 ......................................................................37
Figure 2.11. Dextran Sulfate Release Assay of zPEI complexation with pUC19 plasmid
........................................................................................................................39
Figure 3.1. Polycationic complexes have been shown to pack into hexagonal lattice
conformations .................................................................................................44
Figure 3.2. Representation of radiation scattering off of a crystalline packing pattern .....47
Figure 3.3. A. The teflon chips and steel mount used to hold the polyplex pellet in place.
B. SAXS setup used to collect data ................................................................51
Figure 3.4. Left: Scattering diffraction pattern of a PEI/DNA polyplex complexed at a
weight ratio of 1.5. A beam stop is visible as a dark diamond. Right: Radial
integration from the center of the imaged scattering profile. A clear Bragg
peak at a q value of ~2.3 nm-1 is visible ........................................................52
Figure 3.5. Plots of intensity vs. Q (nm-1) for PEI derivatives complexed with CT-DNA
........................................................................................................................54
Figure 3.6. Plots of intensity vs. Q (nm-1) for PEI derivatives complexed with CT-DNA
following one week of incubation. .................................................................55
Figure 3.7. Bragg spacings of zPEI samples collected after 1 week incubation ...............57
Figure 3.8. Bragg spacings of zPEI samples collected over the course of 1 month ..........58
Figure A.1. Characteristic normalized FCS autocorrelation curves of diffusion of Alexa
488 NHS ester (-2 charge) through a 10 mM MES buffer (pH = 6.4) solution
........................................................................................................................67
Figure A.2. Translational diffusion coefficients (D) of Alexa 488 in increasing
concentrations (% wv) dextrans......................................................................68
Figure A.3. Characteristic normalized FCS autocorrelation curves of diffusion of Alexa
488 NHS ester (-2 charge) through a 10 mM MES buffer (pH = 6.4) solution
of 6% wt dextran at a variety of mixing ratios of equal concentrations of
dextran(+) and dextran(-)................................................................................70

vii

Figure A.4. Translational diffusion coefficients (D) of Alexa 488 in 4, 6, and 8 % wv
mixed solutions of dextran(-) and dextran(+) .................................................71
Figure A.5. Snapshot of a disordered lattice BD simulation .............................................72
Figure A.6. Translational diffusion coefficients (D) of Alexa 488 in 4, 6, and 8 % wv
mixed solutions of dextran(-) and dextran(+) presented against simulation
data ..................................................................................................................73

viii

Chapter 1: Introduction
1.1. Introduction to Gene Delivery by Chemical Transfectors
Many human diseases result from mutations in genetic material that lead to poor
regulation of gene expression or transcription and translation of flawed proteins. For
example, cancer is caused by mutations in oncogenes, which leads to unregulated cellular
proliferation1. Cystic fibrosis results from an inherited mutation to the gene encoding
CFTR, a chlorine ion channel, which leads to mucus buildup affecting lung function2.
Other than treatment of symptoms, increasing understandings of the genetic origins of
disease has promoted efforts to modulate expression or introduce non-pathogenic copies
of genes3. Additionally, introduction of genetic materials into cell cultures and animal
models has become invaluable to the study of protein function as well as study of disease
and therapeutics4. While the gene therapy field once showed great potential, the small
number of clinical trials and lack of pharmaceutical application has resulted from
inadequacies in current delivery techniques.5-6 In order to be effective in treatment, a gene
carrier must be nontoxic, must protect the gene from extracellular and intracellular
degradation, must be able to deliver the gene into the cells of interest, and must release its
cargo into the nucleus or cytoplasm so that it can be transcribed.5, 7
Existing transfection techniques can be grouped into two categories: viral and nonviral. Because viruses have been subject to natural selection, they have evolved with
characteristics to overcome the major obstacles of transporting DNA into a host cell.5
While viral based vectors sport very high transfection efficiencies, their widespread use is
limited due to a variety of factors. Both adenovirus and retrovirus derived vectors suffer
from risk of contamination with an active “helper” virus, and limitations in size of DNA
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payload.8-9 Adenoviral vectors currently are limited in efficiency, partially due to being
limited by the cell host’s life cycle.8 Retrovirus derived vectors suffer from risk of
immunogenic response, of accidental infection with a self-replicating virus, and of faulty
replication of the gene of interest by reverse transcriptase.9 Such an error could result in
higher expression of a faulty gene, worsening or accelerating the targeted disease. These
concerns have been amplified by the death of early participants in clinical trials, such as
Jesse Gelsinger, who died in 1999 as a result of viral injection in an attempt to cure his
ornithine transcarbamylase deficiency (OTC), setting viral delivery research back as a
result of the public backlash.

10

Physical methods such as microinjections or

electroporation show limitations in efficacy due to potential for cellular damage.7 In
addition, they are often low throughput, and difficult to apply to organisms of high cellular
diversity.7 While current chemical agents show lower efficiencies than viral vectors, their
reduced risk of immunogenicity along with large variability in chemical structure and ease
of production give them high potential as gene carriers.5, 7
Cationic polymers, such as polyethylenimine (PEI) and polyamidoamide
(PAMAM), along with peptides and lipid carriers, are among the most well studied
chemical transfection agents.7 A commonality between the major chemical transfectors is
the ability to interact with and bind to DNA through electrostatic interaction with the
negative phosphate backbone.4-5, 11

While lipid carriers, such as lipofectamine, are well

established transfection agents for laboratory cell work, poor performance in vivo, as well
as difficulty of consistent sample preparations limit their application in a clinical setting.5,
11

Cationic polymers, such as polyethylenimine (PEI) and polyamidoamine (PAMAM),

suffer from high cellular toxicity and low transfection efficiency when compared with viral
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vectors, but their use carries a much lower risk of infection or of an immune response.5
Because their chemical structures and properties are readily tunable, a great potential exists
for optimization of commercially available cationic polymers for transfection.5 While it is
clear that a relationship exists between the structure of chemical agents and their ability to
deliver DNA for expression, the field still lacks rigorous characterization of the parameters
that lead to transfection. Previous research has shown improved transfection efficiency
and cytotoxicity in polyplexes, polycation-DNA complexes, by reducing nonspecific
interactions with proteins, blood and other biological components; in addition to loosening
the strength of the interaction between the polymer and the nucleic acid payload, to
facilitate more efficient cellular release.12-25 This has been accomplished through addition
of charge neutral hydrophilic groups such as PEG by grafting, use of negatively charged
copolymers, reduction of charge by covalent modification, and through addition of
hydrolysable charge shifting groups.12-25 A better understanding of how such alterations
modulate the properties of interaction between chemical agents and their nucleic acid
payload is needed for continued progress in creating improved molecules for gene delivery.
Previous work by the DeRouchey group has shown, surprisingly, that mixed charge
peptides are capable of condensing DNA. The resulting DNA packaging is influenced by
both the number and chemical nature of the negative moiety. In this thesis, we have
modified a commercial 25 kDa branched polyethyleneimine (bPEI) polymer through
reaction with succinic anhydride to form mixed charge, or zwitterionic, PEI (zPEI). By
modulating the ratio of PEI to succinic anhydride, a series of zPEI were synthesized with
varying degrees of modification through reaction of succinic anhydride with primary and
secondary amines on bPEI. With a combination of structural studies in addition to cell

3

work performed by collaborators in the laboratory of Dr. Dan Pack (University of
Kentucky, Chemical and Materials Engineering), we have explored how the percent
modification of zPEI affects the binding, protection, and release properties, as well as the
packaging density of the resulting polyplexes. Our hypothesis is that zwitterionic PEI will
provide the ability to systematically tune polymer-DNA interactions leading to polyplexes
with enhanced intracellular unpackaging and more efficient gene delivery. At high percent
modification, we anticipate the polymer-DNA interactions are too weak for effective DNA
delivery, thus an optimal ratio of modification should be determined for zPEI. Generally,
for nonviral delivery of polymers, a large excess of polycation (typically amine based) must
be used to form stable colloidal nanoparticles suitable for DNA delivery. As these
polycations are generally toxic to cells, we also hypothesize zPEI will result in polymer
carriers with reduced cellular toxicity. This chapter will broadly review existing literature
on polycationic transfection agents. The following chapters will detail the synthesis and
characterization of the zwitterionic PEI (zPEI) along with biophysical characterization
(chapter 2) and x-ray studies on DNA polyplex formation (chapter 3).

4

1.2. Structure of Polymer Based Transfection Agents

The structures of several common variants of chemical transfectors are shown in
figure 1.1. This work focuses on the cationic polymer transfectors, which will be discussed
in greater detail. Polylysine, one of the first cationic polymers proposed to be used for
delivery of genetic material, is simply a chain of the amino acid lysine conjoined by peptide
bonds between the a-amino and a-carboxylic group of adjacent lysine residues.26 The net
positive charge of the polymer results from the lysyl group containing a primary amine.
Polyethylenimine (PEI), one of the most well established chemical transfection
agents, is made up of repeating ethylendiamine units. PEI exhibits high transfection
efficiency compared to many other polymers and is often considered as a “gold standard”
in gene delivery. Commercially available PEI is often characterized in two ways; by the
average molecular weight of individual polymer chains, and by the presence or absence of
branching in the molecule.27 As pictured in figure 1.1, PEI can be either linear (lPEI) or
branched (bPEI). The amine groups lend a high positive charge to the molecules at
physiological pH. The branched form of PEI (bPEI) contains a combination of primary,
secondary, and tertiary amines, and the linear form predominantly contains secondary
amines.

PEI used throughout this work, 25 kDa bPEI, has been shown by C13 NMR

analysis to contain roughly 31% primary, 39% secondary, and 30% tertiary amines.28 bPEI
is thought to be especially effective due to the presence of these secondary and tertiary
amines, which provide buffering capability over a wide range of pH.29 Acid titration
studies of branched PEI reveal broad pKa distributions.29 Because PEIs are made up of
neighboring amine groups, both the covalent linkage and the close proximity of adjacent
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DOSPA (Lipofectamine)
polylysine

bPEI

lPEI

PAMAM G1
PAMAM
G2

Figure 1.1. Structures of common polymer transfection agents.
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branches alters the pKa of neighboring amines.22, 29 A simplistic example can be seen for
a single ethylenediamine, a symmetric molecule made up of an ethyl group with single
primary amines attached to each carbon.

However, these two, seemingly identical,

nitrogen have different pKas (9.98 and 7.52).29 As the first amine protonates below pH
9.98, the pKa of the unprotonated nitrogen decreases due to the proximity to the charged
amine. Because of the random branching structure and large number of amines per
molecule of PEI, the individual pKas and orders of protonation/deprotonation are not well
established, but mathematical fits of titration data on 500 kDa branched PEI estimate that
at a physiological pH, roughly 80-90% of nitrogen are uncharged.29 Another group, who
studied a 10 kDa variant of bPEI, reported that 70% of nitrogens remained uncharged at
pH 7.4.30 The wide range of pKas of PEI nitrogen make the molecules good physiological
buffers.
Polyamidoamine (PAMAM), another commercially available cationic transfection
agent, differs from both branched and linear PEI in that it is a dendrimer.5, 31 Dendrimers
are named for their branched, “tree like” structure, and are made up of repeating, radial
symmetric branched units around a central “core” molecule.31-32 Because of their high
degree of symmetry, and tight control over parameters, such as surface chemistry and
number of surface groups, dendrimers represent a potential alternative to linear and
disordered branch structures for use in DNA polyplex assembly and delivery.

Higher

generation PAMAM dendrimers are thought to be spherical in form and terminate with an
outer layer of primary amine groups.31 PAMAM dendrimers are typically synthesized by
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a divert method through a repeating two-step reaction process, a Michael addition followed
by amidation, that results in two new branches off of every primary surface amine.

31-32

Every cycle of these reactions is referred to as a new generation, where the number of
reactive surface groups is double the previous generation.31 For example, if the reaction
is terminated after the first cycle on an ethylenediamine (bifunctional) core, the resulting
polymer will be termed PAMAM G0, for generation 0 and have 4 primary amines on its
surface. If the Michael addition/amidation cycle is repeated 4 times, the product will be
third generation PAMAM (G3 PAMAM) and have 32 primary amine surface groups.
PAMAM G1 is presented in figure 1.1. G4 PAMAM was used in this study with 64 surface
amine groups. Titration experiments have shown that the outer primary amines of G4 have
pKas of 9.9, thus possessing charge at physiological pH.33 The effective charge of G4
PAMAM however is expected to be less than +64. Tertiary amines have pKas of ~6.5, and
non-surface group amines of PAMAM are thus believed to be uncharged at physiological
pH. At low pH, such as that found in lysosomes, these tertiary amines may be charged. 3334

Like PEI, PAMAM dendrimers are good physiological buffers.34

1.3. Mechanism of DNA Binding and Delivery

Efficient delivery of nucleic acids for non-viral gene therapies must include means
to successfully navigate several kinetic and energetic barriers; including effective
compaction and particle stability of the polyplexes to be efficiently internalized by cells
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yet sufficiently labile to subsequently release the nucleic acids for delivery.5 A simple
cartoon depicting the barriers to cell transfection is displayed below in figure 1.2.

PEI (+)

DNA (-)

Complexed PEI/DNA
Delivery through
nanoparticle
extracellular space and
through cell membrane

Delivery through cytoplasm
and nuclear membrane

DNA
Release

Figure 1.2. Cellular barriers for effective chemical transfection

The first barrier a chemical transfector must navigate is transportation and
protection of the nucleic acids through a tightly regulated and degradative extracellular
environment.

Naked nucleic acids are not capable of effectively crossing the cell

membrane due to their large size and charge. To overcome this barrier, various condensing
agents have been successfully used to create nanometer sized complexes capable of more
readily carrying nucleic acids across the cell membrane.35 Additionally, degradative
enzymes, such as DNAse, which are present extracellularly and intracellularly, severely
limit the time that cell targets are exposed to unprotected genes.36-37 Condensing agents,
such as PEI, also prevent DNA degradation in cells for several hours.5, 36 DNA particles
bind to polycations spontaneously in dilute aqueous solutions forming nanometer scale
particles called polyplexes.4-5, 11, 38-39 Interactions between DNA and polymer are the result
of electrostatic forces between the negative DNA backbone and the positively charged
groups on the polymer.7 It is believed that this process is made entropically favorable by
the release of counter-ions from the oppositely charged molecules into solution.40-41
Polyplexes are often found to have the highest transfection efficiencies when the number
of positive charges added to DNA is in excess of the number of negative charges from the
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DNA.42 Experimentally, this is represented as a molar ratio of nitrogen to DNA phosphate,
or N/P charge ratio. Excess polycation (i.e high N/P ratios) is required for the formation
of sufficiently small, stable nanoparticles for efficient cellular uptake. 43-45 The small size
of these particles also allows for more efficient diffusion through intracellular and
extracellular fluid.
The positively charged polyplexes are able to associate with the negative head
groups of cellular membrane lipids, which helps to facilitate endocytosis.42 Polyplexes are
believed to enter the cells through three different endocytotic pathways: Clatherindependent endocytosis, the Caveolae pathway, and pinocytosis.46 Once taken up into the
cell through endosomes, polyplexes must be transported towards the nucleus. Fluorescence
studies by Suh, et. Al. suggest that endosomes containing cationic polyplexes likely traffic
near the nucleus by active transport along microtubules.47
The high positive charge density of the polymers contributes to the high buffer
capacity, which is believed to be integral to polyplex release from endosomes for PEI and
other cationic transfectors.29,

48

Both Clatherin-dependent endocytosis and pinocytosis

result in lysosomal degradation of endosomal contents.46 The lysosomal pathway utilizes
low pH along with degradative enzymes to break foreign materials along with recyclable
cell components into their base biological molecules for use by the cell.49 Additionally,
one study by Gabrielson and Pack indicates that acidification also occurs in Caveolae
derived endosomes, even though such vesicles are not destined for lysosomal
degredation.50 The mechanism by which cationic polyplexes are released from endosomes
into the cytoplasm is still highly debated, but the most well accepted idea in the literature
is known as the “proton-sponge hypothesis”. According to this hypothesis, originally
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proposed by Behr, the broad buffer capacity of PEI and PAMAM polyplexes resists
acidification by proton pumps in endosomes.5, 48 In response, proton pumps release more
H+ ions into the vesicles, leading to larger influx of counter-ions.5 Osmotic swelling
accompanies the increase in ion concentration, resulting in membrane rupture and release
of polyplexes.5, 51 Inhibition of endosomal acidification by drugs such as Bafilomycin and
Nigericin lead to significant reductions in transfection efficiency, lending credibility to this
idea.34,

46

Additionally, microscopy studies have visualized endosomal burst in cells

exposed to polycation/DNA complexes.52
While this mechanism has come to be accepted by many in the literature, a handful
of studies call into question the validity of the “proton-sponge hypothesis”. Banjaminsen
et. al. used pH sensor nanoparticles co-localized to the lysosomes with fluorescently tagged
PEI polyplexes to show that the pH of endosomes did not significantly change with the
addition of PEI as would be expected if the concentration of PEI was high enough to cause
endosomal burst by buffering.53 Additionally, estimates of osmotic stress induced by
polycation complexes by this buffering effect do not seem to indicate that endosomal burst
is a realistic outcome.51, 53 For this reason, it was suggested by Benjaminsen et al. that
micron sized pore formation, as reported to be induced by surfactants in liposomes, may
be another possible mechanism of endocytotic escape.53-54 The presence of such pores in
PEI transfections was observed by laser scanning microscopy by Bieber et. al. and have
been proposed to be a source of the toxicity observed.55-56
Once DNA cargo have reached the cytoplasm, they must be transported through the
nuclear membrane. The mechanisms underlying this process are very poorly characterized,
and consensus on the pathway that polyplexes take is still to be reached. It is unclear
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whether or not polyplexes travel through the nuclear membrane intact, or whether DNA
must be released from polymer before transportation. The nuclear membrane is only wide
enough for particles 30 nm or smaller to translocate through, which would preclude many
cationic polyplexes based upon size alone.57-58 A two colored Fluorescence correlation
spectroscopy (FCS) study by Clamme et. al. did not indicate that bound polycation/DNA
complexes existed within the nucleus during transfection, but did show that free polymer
was present inside of the nucleus during transfection.59 Both Clamme et. al. and Suh et. al.
observed accumulation of PEI/DNA complexes was observed in the cytoplasm around the
nucleus.47,

59

Additionally, it has been suggested that transfection efficiency may be

dependent upon cell cycle, with efficiency increasing during mitosis, when the nuclear
membrane breaks down.60 In fact, transfection studies of polymer and lipid transfections
show higher efficiency in actively dividing cell cultures.61-62 Alternatively, efforts have
been made to add nuclear localization signals to genes of interest to increase nuclear uptake
in non-dividing cell cultures, which are of interest for clinical applications.60
Whether it be intranuclear or perinuclear, several mechanisms for DNA release
from polymer have been proposed. DNA release could be mediated by competitive binding
of the cationic polymer with nucleic acids, most likely RNA, or other negative cell
components.63-64 Additionally, if the polyplex exists in the nucleus, Thomas and Klibanov
have suggested that DNA could be stripped away from the polymer by the DNA
polymerase complex, as has been observed to occur with histone bound DNA.7,

65

Regardless of the mechanism of endosomal escape, cell transport, and nuclear
translocation, it is clear that very few of the DNA molecules transfected end up in the
nucleus, and the majority are degraded in the cytoplasm.60
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While the positive charge of cationic DNA polyplexes confers characteristics that
enhance transfection, it also comes with several drawbacks. Polyplexes can bind to cell
structures, such as proteins and membranes, which can lead to cell death.66-67 Additionally,
in vivo, the positively charged polyplexes can bind to blood cells and negatively charged
blood proteins, which lowers the efficiency of delivery.17, 68-69 One study by Hong et. al.
has shown that the high positive charge of polyplexes can lead to increases in permeability
of membranes through pore formation, which in excess is deleterious for cells.56
A large number of factors, at times competing with one another, govern the
effectiveness of cationic transfectors. An effective chemical agent must be capable of
binding and condensation of DNA cargo, protection of payload from enzymatic
degradation, and mediation of transport through the extracellular space into the cytoplasm
and nucleus of the cell. However, the nucleic acids must not be so tightly bound that they
are unable to be released and transcribed by the target cell, nor should the polyplex be
harmful to cells or tissues.

Development of better chemical transfectors, therefore,

necessitates careful consideration of these factors that influence polymer/nucleic acid
interactions.

1.4. Attempts to Optimize Gene Delivery

Because the commonly utilized commercial polymers, such as PEI and PAMAM,
were not made to address the diverse barriers associated with gene delivery, great potential
exists to modulate their chemical properties in order to better optimize ability to transfect.
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As discussed above, successful gene delivery requires overcoming various energetic
barriers. Often these barriers are in direct competition and therefore an optimization of
these barriers is required. Because a high net positive charge is a common trait in chemical
transfectors, many groups have studied the effects of charge reduction or modulation upon
the efficiency of transfection. As described in the previous section, a high nitrogen to
phosphate (N/P) ratio is necessary to condense polyplexes into stable nanoscale particles,
and is important for endosomal escape into the cytoplasm, but can also be deleterious to
cells and cause nonspecific interactions with components of blood and other tissues.
Through reduction of the overall positive charge of the polymer, the affinity of DNA
release may be modulated, as well as the extent of binding to negatively charged cellular
components or blood/serum proteins. If an optimal charge density can be established, the
limits of transfection efficiency and cytotoxicity of the base polymer may be improved in
vitro and in vivo. There are several modes by which various groups have accomplished
this goal. By grafting biocompatible and neutral groups such as polyethylene glycol (PEG)
or dextran carbohydrate chains to PEI, several groups have noted a reduction in
cytotoxicity and an increase in transfection efficiency over the base polymer.16-19
Additionally, creation of tertiary complexes, by addition of an anion to polyplexes after
complexation is believed to reduce cytotoxicity and nonspecific binding to proteins by
reducing the positive charge on the outside of polyplexes, and through binding up free
polycation in solution following preparation.12-15 In addition to these two means of charge
modulation, many groups have sought to reduce charge through covalent reaction of the
positive amine groups. Acetylated branched PEI through creation of an amide bond on the
primary and secondary amines was shown to decrease the binding affinity for DNA,
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increase the intracellular release, and overall increase transfection efficiency up until a
critical percent modification.21-22 Other groups have shown PEI with covalently attached
neutral zwitterions such as 2-methacryloyloxyethyl phosphorylcholine (PMPC) is both less
cytotoxic and a more potent transfector than unmodifiedPEI, which is very similar to what
was observed in PEG grafting onto PEI.23-24 Additionally, work has been done by Lynn
et. al. to create “charge-shifting” PEI derivatives that, when hydrolyzed over time, lead to
an increase in negative charge along the polymer.25 This approach has shown that a time
based zwitterionic modulation of PEI can also lead to increases in transfection efficiency.
The success of modification studies such as these indicate the potential for fine tuning the
transfectibility of chemical agents by modulation of their positive charge, and suggest that
further optimizations may lead to more viable chemical agents that are better able to
compete with viral based methods.
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Chapter 2: Synthesis and Characterization of Zwitterionic PEI
2.1. Introduction

While the high cationic charge of PEI lends itself towards high cytotoxicity and
low serum stability; it also allows for the condensation, tight packaging, and endosomal
escape necessary for gene expression.5, 36, 55-56, 66-69 Not only must DNA be tightly packaged
and protected from enzymatic degradation, but also must be released at an appropriate
cellular location.5, 7, 36-37 For this reason, a balance in the charge content of PEI through
addition of zwitterionic character could lead to optimal transfection. Previous work by the
DeRouchey group indicated that mixed charge peptides were able to condense DNA. Here,
zwitterionic charge was introduced to 25 kDa branched polyethylenimine (bPEI) through
addition of succinyl groups through post polymerization modification. In collaboration
with the laboratory of Dr. Pack, a spectrum of succinylated PEI derivatives (zPEI) were
created. This chapter will explore the relationship between percent modification of zPEI
and the resulting binding and release properties of DNA with the polymer.

2.2. Materials and Methods
2.2.1. Materials

Branched 25 kDa PEI, succinic anhydride, hydrochloric acid (37%), solid sodium
hydroxide, dextran sulfate, D2O, and sodium azide were purchased from Sigma Aldrich
(St. Louis, MO). Sodium Carbonate, 10 x phosphate buffered saline, ethidium bromide,
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30% glycerol, 2k MWCO Slide-A-Lyzer dialysis cassettes, and 0.5 M EDTA were
purchased from ThermoFisher Scientific (Waltham, MA).

Sodium Bicarbonate was

purchased from EM Science (Darmstadt, Germany). Tris-Acetate-EDTA buffer (TAE,
50x) was purchased from Omega Bio-tek (Norcross, GA). Tris HCL buffer was purchased
from Madiatech, Inc (Manassas, VA). Plasmids pUC19 (1 mg/mL) and pUC18 (0.5
mg/mL) were purchased from New England Biolabs (Ipswich, MA) and ThermoFisher
Scientific (Waltham, MA) respectively.

DNA ladder (1 kB) was purchased from

Fermentas Biotechnology (Waltham, MA). Solid Agarose I, 0.2 micron syringe filter units,
and 1000 mL 0.2 micron PES vacuum filter units were purchased from VWR (Radnor,
PA). Bromophenol Blue was purchased from Eastman Kodak (Rodchester, NY). All
double distilled H2O used was purified through a dH20 – Milli-Q water purification system
equipped with a 0.22 micron Millipak 40 sterile Millipore filter (Billerica, MA).
Acetylated PEI received from Logan Warriner (UK Chemical and Materials Engineering,
Laboratory of Dr. Dan Pack).

2.2.2. Synthesis and Characterization of zPEI
2.2.2.1 Synthesis and Purification of Succinylated PEI

Sodium bicarbonate buffer (0.1 M, pH 9) was prepared by mixing aqueous
solutions of 0.1 M sodium carbonate and 0.1 M sodium bicarbonate. A half gram of 25
kDa branched PEI was dissolved in 3 mL of pH 9 bicarbonate buffer in a 7 mL scintillation
vial. Once dissolved, solid stock of succinic anhydride was added and immediately mixed.
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The amount of succinic anhydride was chosen based upon the intended molar ratio of
substitution. Samples were magnet stirred and allowed to incubate at 60 °C for 4 hours.
Following reaction, solutions were filtered through a 0.2 micron syringe filter. The
resulting solutions were loaded into 2K MWCO Slide-A-Lyzer dialysis cassettes and
allowed to equilibrate with double distilled water (ddH2O) for 48 hours with constant
replacement of the external water solution. After 48 hours, the solutions were emptied
from the dialysis cassettes and frozen at -80 °C prior to lyophilization. Synthesis was
performed by Logan Warriner (Chemical and Materials Engineering, University of
Kentucky) and Joseph Duke (Chemistry, University of Kentucky).

2.2.2.2. H-NMR and FTIR Analysis

In order to evaluate the yield of the reaction and test for the presence of unwanted
side reactions, H1-NMR and FTIR spectra were taken on the succinylated PEI in addition
to the unmodified branched PEI. For H-NMR, samples were dissolved at ~5-10 mg/mL in
dH2O. Percent succinylation was estimated by Logan Warriner from H-NMR spectra
taken on a 400 mHz Varian NMR spectrometer. NMR data processed and integrated using
Agilent VnmrJ software. An iS50 FT-IR equipt with a diamond ATR was used to collect
absorbance data from 4000-400 cm-1 radiation from spectrum on solid PEI stocks through
OMNIC software (ThermoFisher Scientific; Waltham, MA). FTIR data was output as a
CSV file for processing in Origin (OriginLab Corporation; Northampton, MA).
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2.2.2.3. pH Titration

For each of the zPEI derivatives and the unmodified, 2 mg were dissolved into 5
mL of ddH2O. The pH of each sample was adjusted to 11.5 using 1 M sodium hydroxide.
Each solution was then titrated with 5 µL additions of 1 M HCl. Solutions were mixed
well prior to pH measurement on an Accumet AB15 pH meter (Hudson, MA). Titrations
were performed by Logan Warriner and Joseph Duke.

2.2.3. Characterization of DNA Polyplex Formation
2.2.3.1. Gel Retardation Assay

Agarose gel electrophoresis was utilized in order to assess DNA condensation
efficiency of unmodified and modified (uPEI and zPEI, respectively). 200 ng of plasmid
DNA (pUC19 or pUC18) were mixed with the desired weight ratios of PEI. Both DNA
and plasmid was prepared in 10 mM Tris (pH 7.5), 400 µM NaN3 buffer that was filtered
before use with a 0.2 µm PES filter unit. All samples were brought up to a final volume
of 12 µL by addition of Tris buffer, vortexed for ~1 minute, and allowed to incubate at
room temperature for 45 minutes before loading the sample onto the gel. Following
incubation, 2.4 µL of 6x loading dye was added to each sample and mixed. Ten µL of each
PEI/DNA sample was pipetted into the wells of a 0.8% agarose gel and ran at 100 V for
approximately 2 hours in 1xTAE buffer (40 mM Tris pH 8, 20 mM acetic acid, 1 mM
EDTA, made from dilution of 50 x stock into ddH20, passed through a 0.2 µm PES filter.
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Samples were run next to a single well of 20 µg/mL solution of 10 kbase DNA ladder
dissolved in 10mM tris. All agarose gels were prepared by dissolving agarose in 1x TAE
buffer by microwave heating, and allowing to cool for at least 1 hour. Gels were stained
for 45 minutes in a 200 µL solution of 0.5 µg/mL ethidium bromide dissolved in 1xTAE.
Gels were subsequently destained for 30 minutes in 200 µL 1xTAE solution. A BioRad
ChemiDoc MP Imaging System was used to image each gel through Image Lab software
(BioRad; Hercules, Ca).

2.2.3.2. Polyplex stability in the presence of Dextran sulfate

In order to determine the stability of DNA/zPEI complexes, polyplexes of
PEI/pDNA (0.2 ug pUC19) at fixed w/w ratio, chosen based upon the needs of the
experiment as discussed below, were brought to a final volume of 5 µL in 10 mM tris buffer
and incubated for 45 minutes at room temperature. The desired weight ratio of a competitor
polyanion, here dextran sulfate (DS) in 10 mM Tris, was then added to the samples to
induce DNA release. All DS/PEI/pDNA samples were then brought to a final solution
volume of 12 µL by addition of 10 mM Tris. Samples were then vortexed and incubated
for 30 minutes. 2.4 µL of 6x loading buffer and preparing and running 0.8% agarose gel
as described above. A BioRad ChemiDoc MP Imaging System was used to image each
gel through Image Lab software.
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2.2.3.3. DLS Zeta Potential Characterization

Polyplex solutions were formed by preparing a 0.02 mg/mL solution of pBR3
plasmid in 0.1 x PBS.

Polymer solutions dissolved in 0.1xPBS at appropriate

concentrations for the desired weight ratio of polymer to plasmid were added dropwise to
the DNA solution while being mixed. Samples were well mixed and left to incubate at
room temperature for 30 minutes. Polyplex solutions were diluted to 1 µg/mL in 0.1xPBS
prior to measurement. A Zetasizer Nano ZS (Malvern Instruments; Malvern, UK) was
used to collect all DLS and Zeta potential measurements. All DLS and Zeta Potential
measurements and sample preperations performed by Logan Warriner.

2.3. Results and Discussion
2.3.1. Characterization of Synthetic Product
2.3.1.1. Spectroscopic Analysis of zPEI

In order to probe the effect of increased zwitterionic character upon the ability of the
commercial transfecting agent polyethylenimine (bPEI) to condense DNA, a series of
zwitterionic PEI derivatives (zPEI) were synthesized through post-polymerization
modification via succinylation of primary and secondary amines as depicted in Figure 2.1.
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+
Figure 2.1. Reaction scheme for the synthesis of succinylated PEI (zPEI) using
succinic anhydride. Reaction is also possible with secondary amines, but for
simplicity, only substitution upon primary amines are shown.
zPEI with percent modification ranging from 5-35% were synthesized by reaction of
commercially available, 25kDa branched PEI dissolved in 0.1M bicarbonate buffer (pH 9)
with succinic anhydride. Branched PEI is contains a mix of primary/secondary/tertiary
amines, broadly thought to have a ratio of 25/50/25.28 The variant used in this work, 25
kDa bPEI, has been reported by Sigma Aldrich to contain an amine content of roughly 31%
primary, 39% secondary, and 30% tertiary amines. By varying the SA:PEI ratio in the
reaction mixture, polymers with varying degrees of modification are obtained through
reaction with primary and secondary amines. By adjusting the pH to 9 with bicarbonate
buffer, we expected to improve yield of succinylation by deprotonating the PEI amines
increasing the nucleophilicity of the amine nitrogen. bPEI and succinic anhydride were
mixed and allowed to react for 4 hours. Following the succinylation, zPEI samples were
dialysized to remove residual succinic anhydride and freeze-dried.
Total percent of amines reacted was characterized via H1-NMR by Logan Warriner
by division of the integration of peaks representing the succinyl methylene at d 2.3-2.5 by
those representing the PEI ethylene backbone at d 2.6-3.34. H1-NMR characterization
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revealed percent substitutions of 5.8, 8.0, 15.4, 26.7, and 35.0% of total amines reacted for
the 5 different PEI derivatives reacted and purified. A previous paper focused on siRNA
delivery by Zintchenko et al. performed succinylation of PEI but saw a maximum of 20%
amine groups reacted when the reaction was performed in pH 5 solution of water and
DMSO.20 siRNA knockdown was then examined but only at the one percent
modification.20
In order to ensure that the succinylation of bPEI was the primary product, FTIR was
used to characterize the functional groups of our post-polymerization succinylation.
Because different bond types have bending and stretching modes with frequencies on the
order of infrared (IR) radiation, IR absorption spectra of a sample can be used to identify
functional groups of interest.70 Of concern was the potential for unintended side reactions,
namely crosslinking or ring closure to form a succinimide group (figure 2.2). Both
formation of succinimides and crosslinking, either via intra- or inter-molecular nitrogen,
would reduce the overall charge at neutral pH by replacement of amine groups with amide
groups with reduced pKa values, in contrast to the production of zwitterionic character that
was intended.

Inter-molecular crosslinking would lead to larger molecular weight

branched PEI derivatives, which would also confound the effects of charge modulation.
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The resulting IR absorbance spectrum of our 5 zwitterionic derivatives of branched
PEI, along with the unmodified, are depicted in figure 2.3 below. In unmodified PEI, two
peaks at ~2934 cm-1 and ~2815 cm-1 indicate the presence of C-H stretches corresponding

Figure 2.3. FTIR Analysis of Succinylated bPEI Derivatives

to the ethyl groups present in PEI. The peaks at ~3349 cm-1 and ~3270 cm-1 indicate the
N-H stretch of primary and secondary amines. As the percent modification increases, the
first of these peaks is diminished in intensity, indicating the disappearance of primary
amines. The two peaks at 1592 cm-1 and 1456 cm-1 correspond to the N-H and C-H bends
in the amine and ethyl groups respectively. As percent succinylation increases, bands
appear at 1629 cm-1 and 1548 cm-1 indicating the presence of a C=O stretch in the amide
bonds and carboxylate groups created, and at 1393 cm-1 indicating C-O stretches in the
carboxylate of the succinyl group added. A broad peak appears between 3500 and 3000
cm-1, which is likely due to the presence of an O-H bend on the succinyl group COOH, but
could also represent hydrogen bonding between succinyl groups and PEI amines. A sharp
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peak at ~1750 cm-1 indicating the C=O stretch of a succinimide group was not detected in
any of the spectra taken, which is evidence against succinimide formation as a side
reaction. It is difficult to say whether or not crosslinking is evident from the spectroscopic
analysis performed, but high molecular weight inter-molecularly crosslinked products are
likely to be largely eliminated by the filtration of products following synthesis. During
synthesis, insoluble precipitation was observed, likely high molecular weight crosslinked
PEI, but filtration through a 0.2 micron pore size was used to remove precipitants prior to
dialysis and lyophilization. Zeta potential and gel electrophoretic data later discussed in
sections 2.2.2 indicate the presence of negative charge in addition to the reduction of
positive charge, likely meaning that if side reactions were present, they did not entirely
remove the added negative charge of the succinyl groups.

2.3.1.2. Effect of Percent Succinylation on Buffering Capacity of zPEI

As described in chapter one, the buffering capacity of polycations is not only
indicative of the charge density due to amine groups, but also has been proposed to
influence the mechanism that polyplexes are able to escape the endosomal compartments
in target cells. To better characterize the effect of succinylation upon the buffering
capacity, titrations on 0.4 mg/mL solutions of our modified zPEIs, along with unmodified
PEI and water. The ability of zPEI to buffer aqueous solutions is related to the amine,
amide, and carboxylic content of the modified polymers. As previously described in
section 1.2, the amine groups of PEI possess a wide range of pKa, beginning at 9.98 and
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decreasing as protonation of amines increases. 22, 29 Carboxylic groups typically buffer at
much lower pH, having pKa ~ 4. Additionally, amides buffer at a pH of ~ 0. Therefore,
the buffering capacity of zPEI should be proportional to the substitution ratios, as
characterized by H-NMR. The titration curves are shown in figure 2.4. As percent
substitution increases, the titration curves shift to the left, indicative of a reduction in ability
of the polymers to buffer over the pH range tested.

Figure 2.4 Titration of zPEI Derivatives with HCl. Prior
to measurement, all samples titrated to a pH of 11.5.

Extent of buffering capacity was estimated as the number of µmol of HCl necessary to
shift the pH of the PEI solutions from 7.4 to 4. This ph range was chosen because it is the
relevant range of buffering between extracellular pH and the acidic pH of endosomal
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compartments. Table 2.1 below shows the buffering capacities of zPEI as compared with
the unmodified and water. Buffering capacity was calculated as follows:
𝛽=

$%&'()*
|∆-.|(0123345 )

(Equation 2.1)

The buffer capacity, b, is expressed in terms of µmol strong acid per L buffer solution. For
all but between 8.0% and 15.4% substituted zPEI, the buffering capacity between pH 7.4
and 4.0 decreases as percent substitution increases. It is likely that no difference in
buffering capacity between 8.0 % and 15.4 % zPEI was detected because of the simplicity
of the calculation in addition to limitations in resolution of our titration.

Table 2.1 Extent of buffering of succinylated bPEI derivatives
Sample

Buffering Capacity (µmolH+/mLbuffer)

uPEI

3.53

5.8% zPEI

3.24

8.0% zPEI

2.35

15.4% zPEI

2.35

26.7% zPEI

2.06

35% zPEI

1.76

ddH2O

0.59

2.3.2. Characterization of Complex Formation and Dissociation
2.3.2.1. Complex Formation and Dissociation of zPEI

Agarose gel electrophoresis was used to characterize the binding affinity and
polyplex stability of our zPEI/DNA and uPEI/DNA polyplex nanoparticles. For all percent
27

modification, DNA migration in the gel is markedly retarded with increasing uPEI or zPEI
concentration, showing that all PEIs investigated are capable of condensing DNA. We
hypothesize that both polyplex condensation and complex stability will be highly
dependent on the percent succinylation in the zPEI samples.
In agarose gel electrophoresis, a current is passed through an electrolyte containing
solution through a polymerized gel. DNA samples are negatively charged, so when
exposed to an electric current, DNA will migrate away from the negative cathode and
towards the positive anode.

Due to steric constraints when diffusing through the

polymerized agarose it was loaded, smaller DNA molecules will diffuse more quickly than
larger ones. For this reason, agarose gel electrophoresis can be used to separate and
visualize molecules both by charge and mass. A simple schematic of an agarose gel setup
is shown below in figure 2.5a. DNA containing agarose gels are often stained with
ethidium bromide, and intercalating agent, in order to fluorescently image the location of
DNA bands following running of the gel. In figure 2.5b, a typical agarose gel image of
pUC19, a 2686 base pair containing plasmid, is shown. The supercoiled, or tightly wound
and compacted variant of the plasmid is labelled s, and it diffuses further than the band
labelled n and l, representing the nicked open coiled and linear conformation of the
plasmid, respectively. The presence of damaged plasmid (bands n and l) in the commercial
plasmid is a result of the method of synthesis and purification of the DNA.
Gel retardation assay was used to visualize the disappearance of plasmid DNA
bands with increasing amounts of polymer to quantify the relative affinity of zPEI for
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Figure 2.5. a) simple schematic of agarose gel electrophoretic on plasmid
DNA. b) representative gel bands of the supercoiled (s), nicked open
coiled (n), and linear variants (l) of pUC19 plasmid next to a 1 kB DNA
ladder

binding DNA. As the amount of polymer added to DNA increases, the amount of free
DNA in solution will decrease. When run in a gel with progressively increasing amounts
of polymer, the effect will be a disappearance, and in some cases a smearing, of the DNA
bands. DNA polyplexes gain positive charge, and are unable to migrate towards the
positive anode. For this reason, bound DNA either becomes entrapped in the loading wells,
or diffuses towards the negative cathode, out of the gel. Smearing is presumably observed
due to the presence of noncondensed DNA molecules which are still interacting in some
manner with the polycation thus retarding the DNA migration.
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Shown in Figure 2.6, is the gel retardation assay of 0.2 µg pUC19 with varying
weight ratios of uPEI and zPEI. The plasmid DNA exists primarily in the supercoiled form.
For uPEI, complete condensation was observed by electrophoresis at weight ratios of 2
(N/P = 15.4) as visualized by the complete disappearance of the supercoiled band in the
gel in Fig. 2.6A. As anticipated, more zPEI was required for complete condensation with
increasing percent modification. A weight ratio of approximately 6 is necessary to
visualize disappearance of DNA bands in 35.0% succinylated PEI (Fig 2.6F). There is
some ambiguity between 8.0% and 15.4% succinylated PEI which may suggest
imperfections in our H-NMR characterization (Fig. 2.6C-D). It is also possible that
different substitution ratios differ in the numbers of primary and secondary amines that
reacted to form succinyl groups. Differences in the location and distribution of charge on
the surface of the polymer, or on the inside could lead to varying properties of complexation
with DNA. These results reveal that the zPEI samples examined were able to condense
plasmid DNA. However, with increasing percent succinylation, more zPEI was required
to fully condense the DNA.
Polyplex stability was also examined using a gel shift assay. Through the addition
of a polyanion competitor, polyplex DNA can be released and visualized by gel
electrophoresis. The amounts of competitor required to release DNA is then directly
related to the stability of the complex. Here, we have used dextran sulfate (DS) as our
competitor polyanion. DS was found to be both cheaper and more effective in DNA release
compared to another commonly used competitor, heparin sulfate. uPEI and zPEI
polyplexes were formed as discussed previously. Since the highest required weight ratio
for 35% zPEI/DNA was observed to be 6 (Fig 2.6); all DNA release assays were performed

30

at this weight ratio. DNA release assays upon addition of DS is shown in Figure 2.7uPEI
shows complete release after a weight ratio of 10 DS to DNA. zPEI shows release is
dependent on the degree of succinylation in the condensing agent. For zPEI, less competing

Figure 2.6. Gel retardation assay of zPEI complexation with pUC19 plasmid. A)
Unmodified bPEI B) 5.8% zPEI C) 8.0% zPEI D) 15.4% zPEI E) 26.7% zPEI F)
35.0% zPEI

31

Figure 2.7. Dextran Sulfate Release Assay of zPEI complexation with pUC19 plasmid.
Complexes formed at weight ratio PEI/DNA of 6. A) Unmodified bPEI B) 5.8% zPEI
C) 8.0% zPEI D) 15.4% zPEI D) 26.7% zPEI E) 35.0% zPEI
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polyanion (DS) is required to release DNA with increasing percent modification of the PEI.
Like the previous figure, there is some ambiguity between 15.4% zPEI and 26.7% zPEI,
which seem to show the opposite trend in Figure 2.7. In a similar fashion to what was seen
with the binding gels of zPEI, this may suggest inadequacies in our current methods of
characterization between these two polymers. In particular, it is possible that the 15.4%
zPEI contains a different ratio of substituted primary and secondary amines.
The colloidal properties were also investigated for these polyplexes using dynamic
light scattering (DLS) and Zeta potential measurements to characterize the size and charge
of zPEI/DNA polyplex nanoparticles. DLS correlates the scattering of light off of particles
in solution with Brownian motion in order to measure the magnitude and variance of the
hydrodynamic radius of molecules.71

Zeta potential analysis correlates the Doppler shift

in frequency of scattered light off of particles in solution under an applied current from an
electrode.72 This allows for quantification of a “zeta potential” (mV) which is directly
related to the sign and magnitude of particle surface charge.72 Polyplexes were prepared
at a PEI/DNA weight ratio corresponding to the optimal conditions for transfection, as
established in HeLa cell cultured performed by the Pack laboratory.73 The measured values
for radius and zeta potential are shown below in table 2.2. No clear trend was evidenced
from this data as a function of the degree of modification. All particles, except for the
26.7% zPEI, had radii under 300 nm, indicating that zPEI molecules are still suitable for
cell uptake in delivery applications. The radii of zPEI are larger in scale than the
unmodified polymer, likely due to the reduction in positive charge density in DNA/PEI
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particles, which reduces the electrostatic repulsion between molecules. The zeta potential
of all zPEI derivatives, except for 35% zPEI, remained cationic. Only 35% zPEI shows a

Table 2.2 DLS and Zeta Potential Measurement of zPEI Derivatives
Sample

Radius (nm)

Zeta Potential (mV)

Optimal w/w PEI/DNA*

uPEI

61.3 ± 10.3

15.1 ± 2.0

1

5.8% zPEI

174.4 ± 9.68

15.0 ± 1.8

2

8.0% zPEI

286.6 ± 2.8

11.9 ± 2.1

4

15.4% zPEI

205.3 ± 2.8

9.62 ± 1.2

4

26.7% zPEI

669.8 ± 37.76

11.8 ± 1.8

4

35% zPEI

139.6 ± 14.6

-1.3 ± 1.4

4

* Determined by Logan Warriner (Chemical and Materials Engineering) by HeLa transfection

charge reversal resulting in an observed negative zeta potential. We hypothesize that as
positive amine groups are removed by succinylation, neighboring unreacted amine groups
pKa groups are likely to shift upwards, so that even as amines are removed, and negative
succinyl groups are added, the charge of PEI at physiological pH is able to remain net
positive. Only in the 35% substituted zPEI, did the addition of negative charge overwhelm
the positive charge of the polyplex. This is similar to what was observed in acetylated PEI
derivatives by Gabrielson, et al. where acetylated PEI derivatives were able to condense
DNA with positive charge and radii below 300 nm.22 It is likely that the large particle
sizes observed in the 26.7% zPEI and negative potential in the 35.0% zPEI are due to the
addition of zwitterionic character, in contrast to just the removal of amine groups in
acetylation. It is surprising that particle formation between 35% zPEI and DNA only
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produces particles of around 140 nm, even though the net charge on the polyplexes is
negative.

2.3.2.2. Comparison of binding and release properties of a charge neutral modification

Modulation of polymer/DNA interactions by replacement of positive charge with
charge neutral groups has proven to improve the transfectability of cationic polymers. In
particular, the Pack group have shown that the acetylation of PEI can increase the
transfection efficiency of PEI by 58 fold.21-22 A simple schematic of this reaction is
illustrated below in figure 2.8. In order to compare the effect of addition of charge neutral
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Figure 2.8 Reaction scheme for the synthesis of acetylated PEI using acetic
anhydride. Reaction is also possible with secondary amines, but for simplicity, only
substitution upon primary amines are shown.

groups to our zwitterionic modification, identical binding and release agarose gel assays
were run on acetylated PEI (acPEI). Several substitution ratios of acetylated PEI (33.0%,
57.1%, and 93.1%) were provided by the Pack lab and synthesized and characterized as
previously reported.21-22 Acetylation is very similar to the succinylation of zPEI, but
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instead of replacing the positively charged amine group of PEI with a negative succinyl
group, it is replaced with a neutral acetyl group.
The binding gels for acPEI are displayed in figure 2.9 below. A polymer to DNA
weight ratio of 1.75 is required to visualize the complete binding up of pUC19 by 17.1%
acPEI, and a weight ratio of 2.5 is necessary to see complete binding by 37.4% acPEI. The
release gels of acetylated PEI are displayed below in figure 2.10. As acetylation increases,
the amount of dextran sulfate required to cause the full release of DNA also increases.

Figure 2.9. Gel retardation Assay of acPEI complexation with pUC19 plasmid.
A) Unmodified bPEI B) 17.1% acPEI C) 37.4% acPEI D) 68.4% acPEI
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Figure 2.10. Dextran Sulfate Release Assay of acPEI complexation with pUC19
plasmid at a PEI/DNA weight ratio of 6. A) Unmodified bPEI B) 17.1% acPEI C)
37.4% acPEI D) 68.4% acPEI

In contrast to zPEI, acPEI condenses pDNA fully at much lower weight ratios
suggesting a higher affinity for binding. For example, 37.4% acetylated PEI required a
weight ratio of 2.5 to completely condense pUC19 compared to nearly double this amount
to fully condense the plasmid with the comparable 35% zPEI. In addition, the stability of
the acPEI/DNA complex is also higher requiring significantly more dextran sulfate to
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release the DNA. The release of 17.1% acPEI occurs at a DS/DNA ratio of 7.8, which is
roughly double the weight ratio of DS required to release 15.4% zPEI. This effect is even
more obvious for higher degrees of modification. 37.4% acPEI/DNA requires roughly 10
fold more dextran sulfate to release DNA compared to 35% zPEI/DNA. Taken together,
this data suggests that succinylation represents a more potent method of modulating DNA
binding and release character than acetylation.

2.3.2.3. zPEI leads to improved transfectibility and lowered cytotoxicity in HeLa cells

Transfection studies in HeLa cells, performed by the Pack lab, revealed that not
only do low percent modified zPEI (5.8%, 8%, and 15.4%) lead to higher transfection
efficiencies in a serum-free transfection environment, but zPEI is able to achieve
efficiencies exceeding the unmodified polymer in serum.73 Surprisingly, 5.8% modified
zPEI in-serum is able to outperform the efficiency of transfection of uPEI in a serum-free
environment, a rarely seen trait with chemical transfectors. These results have been
replicated in other cell lines including MC3T3-E1 (mouse preosteoblast) and MDA-MB231 (basal like breast cancer cell) where weight ratios were varied to determine an optimal
transfection weight ratio. In order to better understand how succinylated PEI leads to higher
transfection efficiencies, dextran sulfate release gels were run on each zPEI system at their
optimal transfection weight ratios (serum-free HeLa transfection) with respect to DNA.
The results are shown below in figure 2.11.
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Interestingly, the release character for each of the polymers was somewhat similar.
This suggests that affinity for release is quite alike at the optimal conditions for each zPEI.
By adding more or less polymer, the release point of DNA can be tuned, and by adding

Figure 2.11. Dextran Sulfate Release Assay of zPEI complexation with pUC19
plasmid. Complexes formed at weight ratio PEI/DNA corresponding to the optimal
transfection efficiency (Determined by Logan Warriner). A) Unmodified bPEI (w/w 1)
B) 5.8% zPEI (w/w 2) C) 8.0% zPEI (w/w 4) D) 15.4% zPEI D) 26.7% zPEI (w/w 4)
E) 35.0% zPEI (w/w 4).
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zwitterionic character, the release point can be maintained while modulating other
behaviors of the polymer, such as cytotoxicity or binding to serum components.
Cytotoxicity studies by the Pack lab reveal that increasing zwitterionic character leads to a
reduction in cell death when polymer is added to cells.73 This, in addition to the in-serum
transfections that showed superior efficiency compared to the unmodified indicate that
these polymers are able to be modified without losing DNA binding affinity at optimal
conditions. The derivative with the largest deviation from the release point of the
unmodified was 5.8% zPEI. This also happened to be the transfection agent with the
highest efficiency both in and out of serum.73 Out of serum, this polymer performed
roughly 5 fold better in transfection efficiency at a w/w ratio of 2 compared to the
unmodified at its optimal w/w of 1.73 Additionally, large improvements in efficiency were
seen using in-serum transfection conditions. It is possible that this derivative, which holds
DNA more tightly than the unmodified at its optimal weight ratio for out of serum
transfections, reached a more ideal balance of binding character to cytotoxicity and
resistance to nonspecific binding.

2.4. Conclusions

We report here a post polymerization reaction on branched PEI through
succinylation with succinic anhydride. Our spectroscopic analysis, in combination with
titration data and zeta potential analysis, confirm the creation of an array of succinylated
zwitterionic “zPEI”. We have shown that zPEI is capable of binding and condensing DNA,
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forming stable nanometer scale colloidal particles, which are then capable of efficient cell
transfection.

Percent modification is correlated with a loosening of charge based

interaction between DNA and the polymer, affecting both affinity for binding in addition
to extent of release. Zwitterionic modification has been shown to modulate charge based
interactions more aggressively than a similar acetylation reaction (acPEI), requiring lower
substitution ratios to observe a similar effect upon particle formation and dissociation.
These findings, in accordance with cell work performed by our collaborators in the Pack
lab, suggests that charge reduction, along with addition of zwitterionic character, represents
pathways towards creation of improved chemical gene delivery agents.
Future work need focus on better characterization and modulation of substitutions
onto polymer amine groups. Since PEI is made up of primary, secondary, and tertiary
amines, all distributed in different environments within the branched polymer structure,
understanding to what extent different amine types are substituted on will contribute to a
holistic understanding of the effects of post polymerization modification upon DNA
interaction properties. In addition, it may be possible to tune reaction conditions to favor
substitution upon different PEI amine groups, whether they be internal vs. external, or
primary vs secondary amines.

Biophysical, along with cellular characterization of

polyplexes made up of varying amine containing PEI derivatives will further the
understanding of a structure function relationship in cationic transfection agents.

41

Chapter 3: Analysis of Internal Structure of zPEI/DNA
Complexes by Small Angle X-ray Scattering
3.1. Introduction

Chemical transfection agents, such as branched polymer polyethylenimine, have
emerged as strong candidates for use in non-viral gene delivery due to their readily modular
chemical properties in addition to a lower risk for immunogenicity. Previous literature has
shown that chemical modification of PEI, such as PEGylation, alkylation, or the use of
ternary polyanion/Polycation/DNA complexes, lead to reduced cytotoxicity in addition to
improved transfection in cell cultures.12-25 We have recently shown that the addition of
zwitterionic charge through succinylation of the amine groups of branched
polyethylenimine leads to altered binding and release properties of DNA (chapter 2). Cell
work in collaboration with the Pack lab has revealed both a reduction in cytotoxicity and
an improvement in transfection efficiency upon succinylation for zPEI compared to
unmodified PEI (uPEI) both in and out of serum.73
While chemical modifications in polyplex formulations has often been shown to
correlate to improved transfection efficiencies, presumably to altered DNA binding
behavior, the effects of such changes upon the internal structure of polymer/DNA
complexes has not been well established. Design of more efficient materials requires better
understanding of both polymer-NA interactions and how the internal structures in polyplex
nanoparticles relates to intracellular trafficking and gene delivery efficiency. In this study,
we use small angle x-ray scattering (SAXS) to characterize the effect of succinylation on
zPEI/DNA polyplex formation and structure. Because X-ray radiation lies between 0.01-
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100 angstroms, X-ray based techniques are often chosen to study structural information on
condensed molecular systems such as crystals with characteristic distances on the scale of
angstroms.74-75 SAXS is a variant of X-ray scattering used to study structural properties
greater than 10 angstroms.74, 76 Spacing between crystal or semi-crystalline planes can be
determined, and in many cases molecular spacing as well as organization structure may be
elucidated.76 SAXS shows great flexibility with respect to sample preparation, as the
sample analyzed need not be a true crystal, and can be powders, liquids, or DNA
suspensions such as those studied in this work.74,

76-77

Previous studies have shown

mixtures of DNA and polycations (≥ +3), typical leads to self-assembly of the DNA
helixes into a hexagonal lattice (representative image in figure 3.1 below).77 These DNA
helices are not touching, but rather separated by 5-15 Å of water. The DeRouchey lab, and
others, have shown that the interaxial DNA spacings inside the condensates are highly
dependent on cation chemistry. In this Chapter, we use SAXS to determine the DNA
packaging as a function of percent zwitterion modification in zPEI/DNA and compare it to
unmodified PEI/DNA. We also use SAXS to monitor intermolecular assembly over time
for zPEI and uPEI polyplexes.
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Figure 3.1. Polycationic complexes have been shown to pack into
hexagonal lattice conformations.

3.2. Background on Small Angle X-ray Scattering
3.2.1. Generation of X-rays

Radiation with wavelengths between 0.1 and 100 angstroms are termed X-rays.
Because these values are comparable in magnitude to the length of bonds and other
interactions in condensed state materials, they are often used in diffraction experiments to
characterize structure of said materials.74-75 Ka radiation, with wavelength of 1.5418
angstroms is one of the most common wavelengths used in X-ray experiments, and is
generated from electron bombardment of a copper target in an X-ray tube.74-75 In this
method of generation, commonly used for benchtop style X-ray scattering setups, a heated
tungsten filament is used as a cathode, and a negative voltage is applied.70 This results in
the ejection of electrons, which are attracted to the anode due to a positive current applied,
which is attached to the target metal.74 Electrons striking the target metal result in X-ray
production from two main mechanisms. The first is a broad range of wavelengths resulting
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from the deceleration of electrons as they impact the target metal, termed bremsstrahlung
(“brake radiation”).

74-75

Second, sharp peaks, or “characteristic radiation” is produced

when impacting electrons result in ejection of core electrons from the metal target. 74-75 As
higher energy electrons fall to fill this vacancy, photons with characteristic wavelengths
(specific to type of metal used as target) are emitted depending upon which subshell
electrons move from. 74-75 Because the impact of electrons generates heat, the amount of
power applied to the tube and, consequentially the output of radiation, is limited. This can
be partially overcome by using a rotating anode to limit heat buildup on the anode, or a
liquid cooling system may be employed.74 An alternative to X-ray tube setups capable of
much higher radiation output, which allows for shorter periods of measurement and higher
resolution, is use of a synchrotron source.74 In this setup, electrons are radially accelerated
on a circular track at speeds just below the speed of light.74 The acceleration of the charged
electrons produces a broad spectrum of high powered radiation.74 In either synchrotron or
tube based setups, output radiation must often be filtered to include only the wavelength
range of interest to the experimenter. Often this is accomplished by nickel filtration, the
use of crystal monochromators, or polycrystalline filters.74

3.2.2. Small Angle X-ray Scattering (SAXS) Theory

In order to discuss X-ray scattering experiments, terminology used must be
carefully established. When X-ray radiation impacts a sample, the radiation is displaced
in all directions by the electrons in the sample, termed scattering.74
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When X-rays are

scattered by a sample possessing order, such as a crystal or a polycrystalline material, the
scattered rays interfere either constructively or destructively with each other, limiting
which scattered angles can be detected.74 This scattering and resulting interference in
ordered samples is defined as diffraction.74 It is common, however, to interchangeably use
these terms, especially when discussing techniques such as small angle scattering (SAXS)
or wide angle scattering (WAXS), both which make use of diffraction.74 X-rays, like all
electromagnetic radiation, possess both wave and particle behavior.74 They propagate
through space as waves with electronic and magnetic components, both with periodically
repeating amplitudes (over the course of 1 wavelength).70, 74, 78 In order for constructive
interference to occur, parallel photons of light must have overlapping wave functions.70, 74,
78

In X-ray scattering experiments, a wavelength of radiation is chosen that is on the same

magnitude as the spacing of ordered structures in the samples.74 Figure 3.2 portrays X-ray
beams impacting a sample of ordered lattice structure with interplanar distance 𝑑89:;; .70
Radiation scatters off of the top most plane at an atom/molecule at point Z, and off of the
second plane at point B.
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Figure 3.2. Representation of radiation scattering off of a crystalline
packing pattern. Image based upon Figure 12-6 (pp. 279) in chapter 12
of Skoog, Holler, and Nieman’s Principles of Instrumental Analysis (5

th

ed). Radiation depicted as orange dotted lines scatters off of molecules Z
and B that lie in parallel crystal planes in a simple cubic packing pattern.

In order for the two wave functions to overlap and constructively interfere with one
another, the additional distance travelled by the light scattered off of point B must be equal
to some integer multiple of the wavelength.70
AB + BC = nl

(Equation 3.1)

Since AB and BC are equal to 𝑑89:;; sinq, the conditions for constructive interference can
be summed up by the following equation70:
nl = 2𝑑89:;; sinq

(Equation 3.2)

This is known as Bragg’s law, and defines at what angles diffraction can occur. For
crystalline samples made up of one orientation of ordered packing structure, this would
result in defined points of diffraction on a flat imaging surface. When a sample is made up
of many orientations of the same unit structure; such as powders, liquids, or the DNA
47

suspensions examined in this study, the projected diffraction image will be a ring of a radius
proportional to the angle of scattering. If the distance between the detector and sample is
known, the angle of scattering can be established, and 𝑑89:;; can be calculated using
Braggs law. Standards, such as silver behenate, with defined series of Bragg spacings, are
commonly used to calibrate the sample to detector distance for SAXS.79-80 If the unit cell
type can be established, distance between molecules can be calculated from the
𝑑89:;; value. For instance, in a hexagonal lattice unit cell, such as those observed in
polycation/DNA complexes, the interhelical spacing (𝑑<=> ) of DNA molecules represented
in figure 3.1 above could be calculated as follows:
𝑑<=> =

?
@

𝑑89:;;

(Equation 3.3)

Scattering experiments are usually divided into 3 categories based on angles of
diffraction measured: wide angle x-ray scattering (WAXS) is the measurement at angles
greater than 10° (dBragg < 1 nm), small angle x-ray scattering (SAXS) the measurement of
angles between 0.1 and 10° (100 nm > dBragg > 1 nm), and ultrasmall angle x-ray scattering
(USAXS) the measurement of angles less than 0.1° (dBragg > 100 nm).76 To measure
smaller angles, the distance between the detector and the sample must be longer. Because
the angle of scattering is inversely proportional to the spacing of the unit cell planes, the
dimensions of image projected onto the detector are inversely proportional to the
dimensions of the material being imaged. For this reason, it is often useful to describe the
dimensions of the image in units of inverted distance, or inverse space. In our experiments,
we use q (nm-1) to describe the magnitude of radial scattering:
q=

ApB<=q

l
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(Equation 3.4)

3.3. Materials and Methods
3.3.1. Materials

In addition to the synthesized zPEI described in chapter 2, the following materials
were also used. 10 mM tris (400 µM NaN3) was prepared from Tris HCl purchased from
Madiatech, Inc (Manassas, VA) and sodium azide from Sigma Aldrich (St. Louis, MO).
Calf-thymus DNA was purchased from Sigma Aldrich (St. Louis, MO) and suspended in
10 mM tris (400 µM NaN3) as recommended by the manufacturer.

3.3.2. Sample Preparation

Concentrated PEI solution (0.5-1 mg/ml) was added to 300 µg of calf-thymus (CT)
DNA suspended in 10 mM tris buffer (400 µM NaN3) to the desired PEI/DNA weight ratio
resulting in complete condensation of DNA.

UV/Vis of the supernatant confirmed

complete DNA condensation. Samples were made in triplicate. Samples were allowed to
incubate at room temperature for 30 minutes, then centrifuged at 10500 g for 10 minutes.
The condensate gives a white pellet. The condensate was then removed by a glass rod and
placed in 1 mL of 10 mM tris (pH 7.5) buffer and allowed to equilibrate. Samples were
measured after 1 hour, 1 day, 1 week, 3 weeks, and 1 month of incubation. For SAXS
measurements, equilibrated pellets were placed in a home designed Teflon sample holder,
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sealed between Mylar windows in fresh buffer, and measured as described in the
instrumental setup section. For time series measurements, after x-ray exposure, samples
were placed back into fresh 1 mL Tris buffer to equilibrate further until subsequent
measurement. In order to determine sample to detector distance, silver behenate was
mounted in the same sample holder and exposed to x-ray radiation.

3.3.3. Instrumental Setup

A Nonius FR-591 rotating-anode fine-focus X-ray generator (45 kV and 20 mA)
was used to produce CuKa radiation (1.54 Angstroms). Detection was imaged using a
Bruker SMART-6000 Phosphor CCD detector. The teflon sample holder was placed in a
steel holder (figure 3.3a) to mount the DNA pellet in the path of the source radiation. The
pellet was placed in the top of the triangular open window on Teflon holder A, in buffer.
This window was flanked by Mylar films to hold the sample within the holder. The
sandwich assembly was then placed inside of the steel sample holder, with the triangular
portion pointing down, so that the DNA pellet was aligned through the small circular hole
in the holder. This was mounted between the radiation source and the detector with the xray beam aligned to allow passage through the sample. A helium chamber was placed
between the sample and the detector to minimize scattering from air. At the back of the
helium chamber, a lead beam stop was used to prevent the direct beam from reaching the
detector. Samples were typically exposed for 2 minutes. A photo of this setup is displayed
in figure 3.3b. Once imaged by the detector, Fit2D software was used to radially integrate
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the circular diffraction patterns. Origin software was subsequently used to plot scattering
profiles and determine Bragg peak positions. A representative SAXS diffraction pattern of
PEI/CT-DNA polyplex is shown below, along with a radial integration displayed in units
of intensity vs. inverse space (figure 3.4).

A.

Steel mount

Chip A

B.

Chip B (x2)

Mounted DNA sample

Source:
CuKa radiation
(1.54 Angstroms)

Phosphor CCD Camera
Helium Chamber

Figure 3.3. A. The teflon chips and steel mount used to
hold the polyplex pellet in place. B. SAXS setup used to
collect data.
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Figure 3.4. Left: Scattering diffraction pattern of a PEI/DNA polyplex
complexed at a weight ratio of 1.5. A beam stop is visible as a dark diamond.
Right: Radial integration from the center of the imaged scattering profile. A
-1

clear Bragg peak at a q value of ~2.3 nm is visible.

3.4. Results and Discussion

In order to better understand the packing of PEI/DNA complexes as a function of
percent succinylation, a series of SAXS samples were made and measured at various time
points over a period of 1 month. In addition to the unmodified, 5.8 %, 8.0 %, 26.7 %, and
35.0 % zPEI were all measured after 2 hours, 25 hours, 1 week, and 1 month.
Representative scattering profiles of each zPEI/DNA complex are shown below in figure
3.5. A collection of representative samples observed after 1 week of incubation is shown
below in figure 3.6. Bragg spacings are observed to vary considerably with zwitterionic
character. At lower percent substitutions (5.8 % and 8.0 %) the Bragg spacings are
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increased above those measured for unmodified PEI. This is consistent with previous
results by the DeRouchey lab using arginine peptides which showed the insertion of a
negative moiety greatly increased the intermolecular repulsions resulting in significantly
larger interaxial DNA spacings.81 Surprisingly, at 26.7% and 35.0% succinylation, this
trend is reversed, and DNA-DNA spacings decrease significantly below even unmodified
PEI-DNA.
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Figure 3.5. Plots of intensity vs. Q (nm ) for PEI derivatives complexed with
CT-DNA a. unmodified PEI w/w 1.5 b. 5.8% zPEI w/w 2 c. 8.0% zPEI w/w 3.1
d. 26.7% zPEI w/w 4.1 e. 35.0% zPEI w/w 6.1. Weight ratios chosen that
resulted in complete binding of DNA

A plot of Bragg spacings for each sample after 1 week is shown below in figure
3.7. While binding and release gels discussed in chapter two behaved as expected with
increased zwitterionic character leading to reduced strength of DNA interaction, these x54

ray results are unexpected. Previous work in the DeRouchey lab on a similar system, a
succinylated variant of the cationic dendrimer G4 polyamidoamine (zPAMAM), visualized
a time and substitution % dependent phase transition. When unmodified G4 PAMAM and
CT-DNA were mixed at “low salt” conditions, similarly to how zPEI samples were

-1

Figure 3.6. Plots of intensity vs. Q (nm ) for PEI derivatives complexed
with CT-DNA following one week of incubation. Weight ratios chosen
that resulted in complete binding of DNA.
prepared in this study, two distinct peaks were visible during the first two weeks of
incubation.81 These peaks were consistent with a columnar square lattice and a columnar
hexagonal lattice. Over a few months, the square lattice peak disappeared and only the
energetically favored hexagonal phase was observed. The use of a high salt preparation
was observed to overcome this barrier resulting in only a hexagonal phase being observed.
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Interestingly, the zPAMAM/DNA samples even prepared with the high salt preparation
showed the same biphasic behavior as the low salt prepared PAMAM/DNA. With
increasing percent modification, the dominant Bragg peaks observed in zPAMAM/DNA
shifted from the hexagonal phase to the square lattice phase.

One possible explanation

for the changing trends in DNA-DNA spacings with zPEI percent modification could be a
phase transition resulting in a smaller DNA-DNA spacing. Unfortunately, all of the SAXS
spectrum taken on zPEI/DNA only contained one Bragg peak making it difficult to
ascertain information related to the DNA lattice in zPEI. As the packaging in zPEI/DNA
is unclear, for comparative purposes, all measurements reported in this chapter are given
as the phase-independent Bragg spacings instead of the interhelical spacings calculated for
a hexagonal lattice.
The square lattice phase observed in G4 zPAMAM occurs at a larger Bragg spacing
than the hexagonal DNA lattice. Similarly, one would predict for a similar transition in
zPEI, we would observe an increase in the Bragg reflection. However, for the higher
percent modifications (26.7% and 35%) we see the opposite with DNA-DNA spacings
being even smaller than unmodified PEI/DNA. G4 PAMAM contains 256 primary amine
groups localized to the outside of the branched dendrimer. Since DNA likely shows
preferential interaction with the outer primary amines as opposed to the uncharged tertiary
amines on the inside of the dendrimer, the interactions and conformational shifts between
the dendrimer and DNA are likely very different from those observed in a branched PEI
molecule, which can interact with DNA through both primary and secondary amines
located both on the outside and inside of the random branching structure.
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Figure 3.7. Bragg spacings of zPEI samples collected after 1 week
incubation. Each sample complexed at a weight ratio that resulted in complete
DNA binding.

Plots of 𝑑89:;; vs time for all samples measured are shown in figure 3.8.
Unmodified PEI, along with 5.8 % and 8.0 % zPEI, show a time dependent rearrangement
of approximately 5% over one month to smaller DNA-DNA spacings. Samples of 26.7%
and 35.0% zPEI, however, show significantly less rearrangement over time, reaching a
stable conformation in under 24 hours. This suggests that the zwitterionic character of the
zPEI is reducing kinetic energy barriers allowing for faster equilibrium structures to be
achieved over significantly shorter time scales.

57

Figure 3.8. Bragg spacings of zPEI samples collected over the course of 1
month. Each sample complexed at a weight ratio that resulted in complete
DNA binding.

3.5. Conclusions and Future Work

The internal structure of succinylated PEI/DNA polyplexes were investigated by
SAXS analysis. At lower polymer substitution ratios, increased succinylation appeared to
cause an increase in the Bragg spacing of complexes, which can be interpreted as an
opening of polyplex structure due to loosened charge interactions. Unexpectedly, at higher
substitution ratios, zPEI complexed DNA at lower Bragg spacings than observed with the
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unmodified polymer. Additionally, the higher percent modified zPEI complexes showed
significantly shorter time scales to achieve equilibrium structures. Taken together with the
agarose gel studies (Ch. 2) which indicated loosened DNA/polymer interactions with
increasing succinylation, these observations are surprising. One possible suggestion is that
higher percent modifications in zPEI result in a phase transition to a smaller DNA-DNA
spacing in the condensates. To better understand the kinetic barriers to polyplex structural
rearrangement, and the effect of succinylation upon them, a “high salt” preparation,
involving combining concentrated solutions of DNA and polymer in a 2 M solution of
NaCl, may be performed on zPEI in the future. The high salt concentration prevents the
DNA from condensing, allowing both solutions to be mixed homogeneously.
Condensation is induced by the addition of buffer, decreasing the salt concentration until
DNA/polymer condensation occurs.

By allowing for homogenous mixing prior to

condensation, this preparation was shown by DeRouchey et. al. to bypass the time
consuming kinetic rearrangement of DNA/polycation complexes.77 Future work should
also focus on better methods to accurately identify the nature of the succinylation reaction
in zPEI and possible phase transitions. Observation of possible higher order reflections to
allow for assignment of DNA lattice would require a synchrotron source. Orienting DNA
samples may also improve scattering profiles. With this type of instrumentation, it may be
possible to differentiate different lines of symmetry within the structure, and properly
determine lattice conformation as has been previously done by DeRouchey et al.77
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Appendix Section: Diffusion in Polymer Gels with Competing Interaction Sites
A.1. Introduction

Biogels, made up of polymer networks diffusing in an aqueous environment,
perform a variety of physiological functions in organisms, from the lubrication of joints to
regulation of molecular diffusion.82

Fluids containing networks of carbohydrates and

proteins make up biogels such as the extracellular matrix, epithelial mucus, and the basal
lamina of blood vessels are able to regulate passage of messenger molecules, nutrients,
pathogens and other substances to cells.82 Electrostatic interaction, in addition to steric
filtration based upon size, has been determined to be one of the mechanisms utilized in
filtration of biological fluids.83-84 In fact, studies on extracellular matrix and mucin
hydrogels reveals that charge particles may be filtered based upon the magnitude of charge,
rather than the sign of the charge itself.83, 85 Previous collaborative work between the
laboratories of Dr. Jason DeRouchey (Chemistry department, University of Kentucky;
Lexington, Ky) and Dr. Roland R. Netz (Physics department, Free University of Berlin;
Berlin, Germany) have demonstrated the importance of attractive forces in limiting of
diffusion of particles in charged hydrogels.86
Because real biological fluids are heterogeneous mixtures of biopolymers with
disparate chemical and physical properties; models that better approximate real biogels,
containing both attractive and repulsive forces, must be constructed and experimentally
validated. To measure the diffusion of nanoparticles in solutions, such as polymer systems
and tissues, fluorescence correlation spectroscopy (FCS) has previously been utilized. 86-91
FCS allows for measurement of diffusion coefficients (D, µm2/s) of probe molecules
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through time autocorrelation of detected fluorescent intensity fluctuations in a diffraction
limited confocal volume. FCS only measures diffusion of particles that fluoresce at
wavelengths chosen, making the technique highly selective. Additionally, the diffraction
limited spot in solution measured can be on the order of fL, and the concentration of
particles needed for accurate measurement ranges from pM-nM. This allows for reduced
material consumption in sample preparation as well as limited particle interactions in
solution.
Mixed charge gel solutions comprised of positive and negative dextran polymers
were created and the diffusion of a negatively charged probe molecule (Alexa 488) was
experimentally measured with FCS.

Experiments were subsequently compared to

simulated models of mixed charged gels developed by the Netz lab. Their model
approximates a mixed charge gel as sets of fibers with random distributions of charged
“patches” of either positive or negative charge, and finds that particle trapping, and thus
retardation of diffusion, occurs in locations of the gel containing high densities of charge
opposite to that of the diffusing particle.92 Our experimental results were found to be in
quantitative agreement with the model.

61

A.2. Materials and Methods
A.2.1. Materials

The following Dextrans were purchased through Sigma Aldrich: Dextran (Mw =
500 kDa), Dextran (Mw = 15-25kDa), diethylaminoethyl-dextran (DEAE-dextran(+),Mw =
500kDa) and Carboxymethyl-dextran (CM-dextran(-),Mw = 15-20kDa). The 500 kDa and
15-25 kDa dextrans are neutrally charged, while DEAE dextran possesses positively
charged diethylaminoethyl groups, and CM dextran negatively charged carboxymethyl
groups. The following fluorescent dye molecules were purchased from Fisher Scientific:
Alexa Fluor® 488 Succinimidyl Ester dye (Alexa488, Abs/Em peak: 495/519 nm), and
Rhodamine 110 (R110, Abs/Em peaks: 496/520 nm). The fluorescent molecules were
readily soluble in water, and did not require purification prior to use.

A.2.2. Preparation of Dextran Solutions

Dextran stock solutions were prepared by dissolving solid dextran in 10 mM MES
buffer (pH = 6.4) to a final concentration of 8-20 % w/v. Solutions were allowed to mix
for 24 hours following preparation to ensure homogeneity. Stock solutions were used to
prepare experimental samples of appropriate concentration by dilution into buffer to a final
volume of ~500 µL. These solutions were mixed and allowed to equilibrate for an
additional 24 hours. For mixed solutions of DEAE and CM dextran, stock solutions of
each were added together to achieve the desired volumetric ratio of each dextran with
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respect to total dextran. Alexa 488 dye was added to a total concentration of ~5-10 nM,
and this final solution was allowed to incubate, protected from light, for at least 6 hours
before measurement to allow adequate dispersal of the dye molecule throughout solution.
Samples were loaded into NUNC LabTek 8-well microscopy chambers (Nalge Nunc,
Penfield, NY) prior measurement by FCS.

A.2.3. FCS Setup

An Alba fluorescent fluctuation system (FFS) confocal system was used for all
fluorescence correlation spectroscopy (FCS) experiments. A continuous wave 488 nm
laser diode was used as an excitation source.

Excitation light was directed into

experimental samples through a Nikon Ti-U microscope (60x/1.2 NA water-immersion
objective lens). Emitted light was passed through a 514-nm long-pass filter and a 50/50
beam splitter into two pinhole equipped Hamamatsu H7422P-40 photomultiplier tubes for
detection.

Confocal volume dimensions (w0 and z0) were determined through

measurement of aqueous Rhodamine 110 at known concentrations (D = 440 µm2 s-1).93
Routine realignments of detector pinhole/lens sets were performed with R110. In order to
test solution homogeneity, reported results are the average of at least 9 measurements in
different locations in solutions. Sampling times of 30 seconds were used for all
measurements.

A sampling frequency of 200,000 Hz was used, which allowed

autocorrelation over t > 5.0 µs. All fitting was executed through VistaVision 4.0 software
(VWR, Radnor PA).
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A.2.4. FCS Data Analysis

Many have already reported on the theory behind fluorescence correlation
spectroscopy, so a brief synopsis will be described here. 94-95 The measured time traces of
fluorescent events at all times (t) are compared for self-similarity after a lag time (t) by
calculation of the normalized cross correlation, G(t):
𝐺 𝜏 =

EFG > H FG >IJ K L
EG > H LEG > K L

(Equation A.1)

𝛿𝐹(𝑡) and 𝛿𝐹 𝑡 + 𝜏 represent deviation from the mean fluorescence < 𝐹 𝑡 > at time t
and after time t + t. Cross correlation between two different detectors ensures that the
resulting autocorrelation is free from the effects of detector after-pulsing. 95 Assuming that
all fluctuations are due to uniform fluorescent particles diffusing in and out of the confocal
volume by Brownian motion, the following autocorrelation fit was used to model diffusive
behavior:
𝐺 𝜏 =

S
T

∙

S
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S
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(Equation A.2)
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Where tD represents the dwell time of the particles in the confocal volume, whose shape
can be approximated as a Gaussian ellipsoid with axial height z0 and equatorial width w0.
N is the average number of particles occupying the observation volume. The translational
diffusion coefficient D (µm2s-1) can be calculated from tD and the equatorial width using
𝜏\ =

]YZ
A\
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(Equation A.3)

In the case of spherical particles, the Stokes-Einstein equation can be used to relate the
diffusion coefficient to the hydrodynamic radius (rH), solution viscosity (h), and
temperature (T):
𝐷=

_` a
bcd9e

Here, kB represents the Boltzmann constant.

(Equation A.4)
To facilitate visual representation and

understanding, autocorrelations and fits can be normalized by dividing by G(0) and
graphed with 𝜏\ on a logarithmic scale.

A.3. Results and Discussion

Fluorescence correlation spectroscopy (FCS) was used to measure diffusive
properties of charged nanoparticles in solutions containing mixes of both positive and
negatively charged polymers. Alexa 488 was selected as a suitable probe molecule due to
the -2 charge it possesses at a neutral pH. Charged polymer solutions were made from
DEAE Dextran (MW ~500 kDa, 1 DEAE (+) group per ~2 glucose monomers) and CM
Dextran (MW ~13 kDa, 1 CM (-) group per ~4 glucose monomers). To account for steric
effects, Alexa transport in neutral Dextran was also measured. Due to the differences in
molecular weight between the DEAE and CM Dextrans, neutral dextran of comparable
masses (500 kDa and 20 kDa, respectively) was examined. For simplicity, the charged
polymers will be noted as dextran(+) and dextran(-), and the neutral polymers as
dextran500 and dextran20. To ensure solution homogeneity, reported diffusion values for
Alexa 488 are the average of 9 measurements in various solution locations. All solutions
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were prepared from solid dextran stocks without further purification other than that of the
manufacturer.
Normalized autocorrelations for pure solutions of dextran(+) and dextran(-) at
different wt % ratios are shown in figure A.1. Previous studies in the DeRouchey examined
Alexa Fluor transport in Dextran(+) and dextran (-) solutions up to 8 wt%. Here, we also
examined higher wt% solutions up to 15wt%. As was previously observed by the
DeRouchey lab, transport in DEAE dextran was slowest in low wt% solutions (e.g. 2 wt%)
but the measured dwell times by FCS got shorter at higher wt%. This trend continued at
the high wt% solutions studied in this work. The shift to faster diffusion at higher
concentrations of DEAE dextran is likely due to higher concentrations of counter-ions
carried along with the positive dextran, which would screen some of the charge interaction
between the negative dye and the positive DEAE groups.86 Transport through pure
dextran(-) solutions showed the opposite trend, in that as concentration of CM-dextran was
increased, so too did the speed of diffusion. Translational diffusion coefficients for Alexa
488 in various unchared Dextran concentrations (% weight volume) is plotted in figure
A.2. Low wt % results are in very good agreement with the previous report. Previously,
the dextran stock had been dialyzed against ddH2O in order to ensure purity of materials
and remove excess salt.86 As our diffusion values for non-dialyzed samples were nearly
identical to dialysized dextrans, we showed that excess salt content or other contamination
is very low and can readily be discounted as a source of experimental deviation. For the
next studies, we therefore used Dextran solutions as received without dialysis and
lyophilization. In dextran(+) solutions, diffusion of negative Alexa 488 is greatly reduced
compared to the similarly massed dextran500, likely due to electrostatic interaction
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between opposite charges. Probe diffusion is roughly comparable between dextran(-)
solutions and the neutral dextran20, suggesting attractive, rather than repulsive,

A)

B)

Figure A.1. Characteristic normalized FCS autocorrelation curves of diffusion of
Alexa 488 NHS ester (-2 charge) through a 10 mM MES buffer (pH = 6.4)
solution of (A) select wt% dextran (+) and (B) select wt% dextran (-).
Experimental autocorrelations (symbols) are fit (solid lines) as previously
described in order to acquire translational diffusion coefficients.
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electrostatic forces play a large role in modulation of nanoparticle diffusion through a
polymer solution.

Figure A.2. Translational diffusion coefficients (D) of Alexa 488 in
increasing concentrations (% wv) dextrans. All values acquired
through fits of experimental FCS autocorrelations.

Mixed charge dextran solutions were prepared by addition of varying volumes of
equal wt % solutions of dextran(+) and dextran(-) together, followed by mixing and
incubation at room temperature overnight. Charge mixing ratios are represented as volume
of dextran(-)/total dextran volume. For concentrations below 4% weight per volume (wv),
mixing ratios of 0.75-0.9 volume dextran(-)/total dextran resulted in cloudy solutions that
were inhomogeneous and unsuitable for FCS studies. One possible reason for this is that
at concentrations below 4% wv, the concentration of salt from the commercial Dextran
stock are low enough in solution that the release of counter-ions into solution becomes an
entropically favorable condition for complexation between the positive and negative
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dextran to form a coagulate. Representative FCS autocorrelation curves of Alexa 488
diffusion through varying volumetric ratios of the positive dextran to the negative dextran
at a total dextran concentration of 6% wv are shown in figure A.3. Larger amounts of
dextran(-) with respect to dextran(+) are necessary to shift the dwell times of the probe
molecule. This is at least partially explainable by the smaller number of monomers per
charged group on dextran (+) compared to dextran (-). However, the previous report on
probe diffusion through charged dextran showed that repulsive charge between dye and
dextran resulted in a small increase in 𝜏\ compared to neutral dextran, where an attractive
force produced a significant increase in dwell time.86 It is therefore reasonable to assume
that the observed imbalance between 𝜏\ and ratio of dextran(-) to dextran(+) are a result of
both factors. Translational diffusion coefficients for Alexa488 probe molecule in 4, 6, and
8% wv mixed dextran solutions are shown in figure A.4 for various mixing ratios of
Dextran(+) and dextran (-). When dextran(+) and dextran(-) are mixed at a 1 to 1 ratio,
diffusion coefficients are approximately the same as pure dextran(+). Mixing ratios of at
least 0.75 dextran(-)/total dextran are necessary to observe a shift in the translational
diffusion coefficient away from that of the pure dextran(+) solutions of the same total
dextran concentration, suggesting that the presence of positive charge largely determines
the diffusive behavior of the negative nanoparticle through the polymer solution. However,
because translational diffusion values rise with increasing volume ratio of dextran(-)/total
dextran, addition of negative charge does appear to screen the interaction between dextran
(+) and the negative dye molecule.
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Figure A.3. Characteristic normalized FCS autocorrelation curves of
diffusion of Alexa 488 NHS ester (-2 charge) through a 10 mM MES
buffer (pH = 6.4) solution of 6% wt dextran at a variety of mixing
ratios of equal concentrations of dextran(+) and dextran(-). Mixing
ratios expressed as volume of dextran(-)/ volume total dextran.
Experimental autocorrelations (symbols) are fit (solid lines) as
previously described to acquire translational diffusion coefficients.
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Figure A.4. Translational diffusion coefficients (D) of Alexa 488 in 4,
6, and 8 % wv mixed solutions of dextran(-) and dextran(+). D values
are plotted against mixing ratio, expressed as volume of dextran(-)/
volume total dextran. All values acquired through fits of experimental
FCS autocorrelations.

The Brownian dynamics (BD) simulation proposed by the Netz lab consist of a
series of parallel rods, 16 oriented along the x, y and z axis for a total of 48 rods per three
dimensional network.92 Parameters are included for the Brownian motion of the particle,
involving the internal energy and temperature, along with the distance between fibers
(mesh size), diameter of the probe molecule. Disorder could be introduced into the square
lattice structure of this network by increasing a term controlling the standard deviation of
rod placement. Sections of the rods, designated “patches” were randomly assigned to be
positively charged or negatively charged. A representative image of a disordered lattice of
mixed charge is shown below in figure A.5. Notably, the probe particles were shown to
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ordered
𝜎𝑑 /𝑏 = 0

slow with increasing polymer concentration in networks with equal concentrations of
positive and negative charge in both disordered and ordered systems in support of this idea

disordered
𝜎𝑑 /𝑏 = 0.9

suggested from the results of Lieleg and others.83, 85

Figure 1. Tracer position snap shots (red spheres) at di↵erent times for simulations w
Figure
A.5. Snapshot
of a disordered
lattice BD
simulation.
In
competing
interaction
sites (left)
and for purely
attractive
networks
(right) with the sa
interaction strength |U0 | = 15 kB T , an interaction range of k = 0.5s and a e↵ective tra
of high
chargeordered
(blue), the
positivewith
tracera isdisorder
shown tostrength of d = 0
The top locations
and bottom
rownegative
figures show
networks
with d = 0.9, respectively. The algebraic sign of the interaction potential along the
localize,
and become
ensnared.
with permission
fromtrapping mechanisms o
(repulsive)
and blue
(attractive).
TheReprinted
figures illustrate
that the
competing interaction sites are the same as for purely attractive networks. For ordered ne
Hansing, J.; Duke, J.R.; Fryman, E.B.; DeRouchey, J.E.; Netz, R.R.
localization [17] is observed. In the lattice with competing interaction sites (top left), the de
between the vertices and depends on the number of adjacent attractive patches. In the d
Diffusion in polymer gels with competing interaction sites, 2017.
figures) we observe dense fibers trapping [17].

Manuscript to be submitted for publication.

In order to experimentally validate the BD simulation proposed, the model was
tuned to match the parameters of the mixed charged dextrans measured by FCS. By
approximating the mesh size along with the charge per molecule, and the size and charge
of Rhodamine 110, diffusion values for the mixing ratios and concentrations presented in
figure A.4. were calculated. These values plotted against the experimentally determined
diffusion coefficients, are plotted below in figure A.6. Calculated values are in quantitative
agreement with measured values, except for in the 8% wv dextran solutions, where

3
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simulated values appear to overestimate the diffusion of particles, likely due to a misestimation in the effect of hydrodynamic hindrance.

Cdex(-)/Ctotal

Cdex(-)/Ctotal

Cdex(-)/Ctotal
Figure A.6. Translational diffusion coefficients (D) of Alexa 488 in 4, 6, and 8 % wv mixed
solutions of dextran(-) and dextran(+) presented against simulation data. D values are
plotted against mixing ratio, expressed as volume of dextran(-)/ volume total dextran.
Simulation data takes into account the ratio of 5/2 positive to negative charge between
dextran(+) and dextran(-). Reprinted with permission from Hansing, J.; Duke, J.R.;
Fryman, E.B.; DeRouchey, J.E.; Netz, R.R. Diffusion in polymer gels with competing
interaction sites, 2017. Manuscript to be submitted for publication.
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A.4. Conclusions

Using FCS, the diffusion of a negatively charged probe molecule in mixed and pure
charged dextran solutions was measured. At mixing ratios between 0 and 0.75 negative to
positive dextran, the diffusion of the negative probe molecule was nearly identical to
diffusion in a purely positive dextran solution. This is in accordance with the idea that
biogels possessing zwitterionic charge are able to filter out particles based upon the
magnitude of charge, not simply the sign, proposed by Leileg and others. 83, 85 Brownian
dynamic simulations by Hansing and Netz were found to also support this idea of filtration
based upon magnitude, and a mechanism of particle entrapment in areas of high attractive
charge density was observed in model networks. These simulations were found to be
experimentally validated by the diffusion measurements carried out in mixed charge
dextran solutions presented in this work. Future work may focus on creation of new
zwitterionic polymer molecules to further validate simulations. Mixtures of CM and
DEAE dextran are limited in that the charge density on each has not been tuned further
than that of the manufacturer. Additionally, it would be interesting to see if the model
system still finds agreement in polymer systems where patches of positive and negative
charge occur on the same polymer molecule, rather than on separate chains. In this way,
the level of disorder of charge may be modulated in gel solutions.
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